share_log

CBD Life Sciences Inc. Provides Shareholder Letter Update

CBD Life Sciences Inc. Provides Shareholder Letter Update

CBD生命科学公司提供股东信函更新
Accesswire ·  06/24 08:00

SCOTTSDALE, AZ / ACCESSWIRE / June 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. (Formerly LBC Bioscience Inc.) is delighted to announce the transformation of LBC Bioscience Inc. into The CBD Vault Inc., reflecting our commitment to innovation and expansion within the thriving CBD market. Our rebranding marks a pivotal moment as we continue to grow and diversify our product offerings.

CBD Life Sciences Inc. (场外交易股票代码:CBDL) 其全资子公司 The CBD Vault Inc. (前名 LBC Bioscience Inc.) 欣然宣布 LBC Bioscience Inc. 改名为 The CBD Vault Inc.,这反映了我们在欣欣向荣的CBD市场上的创新和扩张承诺。我们的重新品牌标志着一个关键时刻,因为我们继续增长和多样化我们的产品系列。

The CBD Vault Inc. now offers a diverse portfolio of over 60 premium products, including our top-selling pain creams and roll-ons tailored for athletes, as well as Delta-8 & Delta-10 top shelf gummies and cartridges, and a selection of Kava and Kratom beverages.

The CBD Vault Inc.目前可以提供60多种高级产品,其中包括我们畅销的针对运动员量身定制的止痛霜和滚轮,以及Delta-8 & Delta-10顶级软糖和烟弹,以及一系列卡瓦和克拉廷饮料。

In line with the company's growth strategy, The CBD Vault is enhancing its marketing capabilities by recruiting CBD marketing and advertising specialists. This initiative aims to drive greater awareness and revenue for the expanding product line. Additionally, the company is actively exploring opportunities to acquire a marijuana dispensary in the near future along with additional retail locations, further diversifying the market footprint.

配合本公司的增长策略,The CBD Vault正在招募CBD营销和广告专家,提升其营销能力。此举旨在推动扩大产品线的收入及提高客户认知度。此外,本公司将积极探索在不久的将来收购大麻零售店和其他零售店的机会,进一步多样化市场足迹。

The CBD market continues to demonstrate robust growth, driven by increasing public adoption and promising health and wellness trends associated with cannabidiol. The company is committed to capitalizing on these opportunities to deliver value to the shareholders.

CBD市场继续表现出强劲增长,受到人们对大麻二酚有前景的健康和保健趋势的推动。公司致力于利用这些机会为股东提供价值。

Lisa Nelson, President/CEO of CBD Life Sciences Inc., expressed her appreciation: "I am proud of our team's dedication and the significant strides we have made. We owe our success to our loyal consumers and shareholders, and we thank you for your unwavering support." Lisa continued, "By strengthening our marketing efforts and exploring strategic acquisitions, we are positioning The CBD Vault Inc. for continued growth and success!"

CBD生命科学公司的总裁/CEO Lisa Nelson表达了她的感激之情:“我为我们团队的奉献和我们所取得的重大进展感到自豪。我们的成功归功于我们忠诚的消费者和股东,感谢您一直以来的支持。” Lisa继续说:“通过加强我们的营销力度和探索战略收购,我们正在为The CBD Vault Inc. 的持续增长和成功打下基础!”

As always, CBD Life Sciences Inc. remains committed to keeping you informed about new product releases, industry events, and all developments related to The CBD Vault Inc. Explore our comprehensive range of cannabidiol-based organic products on our website at

与往常一样,CBD Life Sciences Inc. 一直致力于向您提供新产品发布、行业活动以及与 The CBD Vault Inc. 相关的所有发展情况。请访问我们的网站,了解我们全面的基于大麻二酚的有机产品。

Thank you for your continued trust and investment in CBD Life Sciences Inc.

感谢您继续信任并投资 CBD Life Sciences Inc。

About The CBD Vault Inc.

关于The CBD Vault Inc。

The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at

The CBD Vault Inc.是CBD Life Sciences Inc.的全资子公司。The CBD Vault已开发并零售/批发了一系列基于大麻二酚的有机产品,包括CBD滴剂、止痛霜、焦虑和睡眠补充剂、食品、咖啡、护肤系列、宠物系列、片剂。The CBD Vault的产品可以在公司的网站上查看和购买。

Follow our social media for the latest updates!

关注我们的社交媒体以获取最新资讯!

X:

博客

Instagram:

Instagram:

IR Contact: cbdvaultaz@gmail.com

IR联系:cbdvaultaz@gmail.com

Forward-Looking Statements

前瞻性声明

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

除了此文中包含的历史信息外,本新闻稿所讨论的事项均为前瞻性声明。实际结果可能与前瞻性声明中描述的结果存在重大差异,并且可能会受到风险和不确定性的影响。请参阅 CBD Life Sciences, Inc. 的 OTC Markets 提交的文件,其中可能指出可能导致实际结果或事件与前瞻性声明中描述的结果存在重大差异的具体因素。

Safe Harbor Statement

Safe Harbor声明

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking.

此新闻稿包含前瞻性声明,基于某些假设,反映了管理层的当前预期。这些前瞻性声明受到多种风险和不确定性的影响,可能会导致实际结果或事件与当前预期存在重大差异。其中一些因素包括:全球经济总体条件;行业和市场总体条件、行业增长率;是否能够从我们的战略和商业计划中获得预期的好处的不确定性;日益激烈的竞争;资本的可用性和成本;识别和开发并实现商业成功的级别;为保持和提高服务质量而必要的支出水平;经济状况的变化;法律和法规的变化,包括编码和标准、知识产权权利和税收事项;或其他未预料到的事项;我们能够确保并维护战略关系和分销协议的能力。公司不承担任何更新或修订任何前瞻性声明的意图或义务。

SOURCE: CBD Life Sciences Inc.

来源:CBD Life Sciences Inc.


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发